Advances on pathogenesis of migraine in cold regions

Abstract

Migraine is a common primary headache which seriously affects the quality of patients’ life due to the high prevalence and disability rate. Recent years a large number of studies have found that temperature is directly bound to migraine and migraine patients in cold regions have higher prevalence, different manifestations and poor response to the conventional therapy. We propose in this review article a new concept of migraine in cold regions on the basis of geography and summarize the research advances on the pathogenesis of migraine in cold regions to provide conceptual basis for the clinical diagnosis and treatment of this disease entity.

Keywords

migraine / cold regions / pathogenesis / genetics

References

[[1]] Ashina M, Katsarava Z, Do T P, et al. Migraine: epidemiology and systems of care. Lancet, 2021; 397(Suppl 3): S0140-6736(20)32160-7.

[[2]] Jensen R, Stovner L J. Epidemiology and comorbidity of headache. Lancet Neurol, 2008; 7(4): 354-361.

[[3]] Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia, 2007; 27(5): 394-402.

[[4]] Scheidt J, Koppe C, Rill S, et al. Influence of temperature changes on migraine occurrence in Germany. Int J Biometeorol, 2013; 57(4): 649-654.

[[5]] Hoffmann J, Lo H, Neeb L, et al. Weather sensitivity in migraineurs. J Neurol, 2011; 258(4): 596-602.

[[6]] Chen R, Kang E, Wu L, et al. Cold regions in China. Journal of Glaciology and Geocryology, 2005; 27(4): 469-475.

[[7]] Akgün N, Acıman Demirel E, Açıkgöz M, et al. The effect of weather variables on the severity, duration, and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache. Turk J Med Sci, 2021; 51(3): 1406-1412.

[[8]] Wang X L, Yin Z M, Lian Y J, et al. Premonitory symptoms in migraine from China: a multi-clinic study of 4 821 patients. Cephalalgia, 2021; 41(9): 991-1003.

[[9]] Vgontzas A, Burch R. Episodic migraine with and without aura: key differences and implications for pathophysiology, management, and assessing risks. Curr Pain Headache Rep, 2018; 22(12): 78.

[[10]] Hung C Y, Tan C H. TRP channels in nociception and pathological pain. Adv Exp Med Biol, 2018; 1099: 13-27.

[[11]] Benemei S, Dussor G. TRP channels and migraine: recent developments and new therapeutic opportunities. Pharmaceuticals (Basel), 2019; 12(2): 54.

[[12]] Dussor G, Cao Y Q. TRPM8 and migraine. Headache, 2016; 56(9): 1406-1417.

[[13]] Burgos-Vega C C, Ahn D D, Bischoff C, et al. Meningeal transient receptor potential channel M8 activation causes cutaneous facial and hindpaw allodynia in a preclinical rodent model of headache. Cephalalgia, 2016; 36(2): 185-193.

[[14]] McCoy E S, Zylka M J. Enhanced behavioral responses to cold stimuli following CGRPα sensory neuron ablation are dependent on TRPM8. Mol Pain, 2014; 10: 69.

[[15]] Proudfoot C J, Garry E M, Cottrell D F, et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol, 2006; 16(16): 1591-1605.

[[16]] Sintas C, Fernández-Morales J, Vila-Pueyo M, et al. Replication study of previous migraine genome-wide association study findings in a Spanish sample of migraine with aura. Cephalalgia, 2015; 35(9): 776-782.

[[17]] Wang P. The research on the correlation between gene polymorphism such as PRDM16, TRPM8, TSPAN2, MMP16etc and migraine without aura. Sichuan Med J, 2016; 37(2): 131-134.

[[18]] Ling Y H, Chen S P, Fann C S, et al. TRPM8 genetic variant is associated with chronic migraine and allodynia. J Headache Pain, 2019; 20(1): 115.

[[19]] Chasman D I, Anttila V, Buring J E, et al. Selectivity in genetic association with sub-classified migraine in women. PLoS Genet, 2014; 10(5): e1004366.

[[20]] Fu X, Yang J, Wu X, et al. Association between PRDM16, MEF2D, TRPM8, LRP1 gene polymorphisms and migraine susceptibility in the She ethnic population in China. Clin Invest Med, 2019; 42(1): E21-E30.

[[21]] Nassini R, Materazzi S, Benemei S, et al. The TRPA1 channel in inflammatory and neuropathic pain and migraine. Rev Physiol Biochem Pharmacol, 2014; 167: 1-43.

[[22]] Materazzi S, Benemei S, Fusi C, et al. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel. Pain, 2013; 154(12): 2750-2758.

[[23]] Kowalska M, Prendecki M, Kapelusiak-Pielok M, et al. Analysis of genetic variants in SCN1A, SCN2A, KCNK18, TRPA1 and STX1A as a possible marker of migraine. Curr Genomics, 2020; 21(3): 224-236.

[[24]] Naert R, Talavera A, Startek J B, et al. TRPA1 gene variants hurting our feelings. Pflugers Arch. 2020; 472(7): 953-960.

[[25]] Bevan S, Quallo T, Andersson D A. TRPV1. Handb Exp Pharmacol, 2014; 222: 207-245.

[[26]] Dux M, Rosta J, Messlinger K. TRP channels in the focus of trigeminal nociceptor sensitization contributing to primary headaches. Int J Mol Sci, 21(1): 342.

[[27]] Zhang X C, Levy D. Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells. Cephalalgia, 2008; 28(3): 276-284.

[[28]] Ma Y T, Deng Q L, Li S G, et al. TRPV1, Targeted by miR-338-3p, induces neuropathic pain by interacting with NECAB2. J Mol Neurosci, 2021; 71(1): 55-65.

[[29]] Horne D B, Biswas K, Brown J, et al. Discovery of TRPM8 antagonist (S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin- 2-yl)methyl)carbamoyl) nicotinic Acid (AMG 333), a clinical candidate for the treatment of migraine. J Med Chem, 2018; 61(18): 8186-8201.

[[30]] Liu Y, Mikrani R, He Y, et al. TRPM8 channels: a review of distribution and clinical role. Eur J Pharmacol, 2020; 882: 173312.

[[31]] Li W, Bertisch S M, Mostofsky E, et al. Weather, ambient air pollution, and risk of migraine headache onset among patients with migraine. Environ Int, 2019; 132: 105100.